在构建临床实用的扩展性携带者筛查面板中寻找中间立场
该评论文章以2013年美国医学遗传学与基因组学学会立场声明和2017年美国妇产科医师学会委员会意见为指导,提出了开发扩展性携带者筛查面板的具体标准,旨在最大化临床实用性并减少患者压力、后续检测的不必要费用及临床医生时间。作者识别出96种符合所提标准的疾病,远多于当前指南推荐;而当前扩展性携带者筛查面板中相当大比例(73%)的疾病不符合所提标准。
要点
- 扩展性携带者筛查比传统指南推荐的携带者筛查更有效地识别更多携带者夫妇。
- 作者提出具体标准以构建临床实用的扩展性携带者筛查面板,识别出96种符合标准的疾病。
- 当前扩展性携带者筛查面板中73%的疾病不符合作者所提标准。
核心结论
- 扩展性面板有好处,但当前状态下患者面临过度压力及为极罕见或轻微疾病和筛查性能低的疾病花费过多时间和金钱进行后续检测的风险。
- 作者鼓励实验室和临床医生合作,为希望获得生殖风险信息的患者创建最具临床实用性的筛查面板。
研究设计与样本
- 本文为评论文章,以2013年美国医学遗传学与基因组学学会立场声明和2017年美国妇产科医师学会委员会意见为指导。
主要发现
- 扩展性携带者筛查比传统指南推荐的携带者筛查更有效地识别更多携带者夫妇。
- 作者识别出96种符合所提标准的疾病,远多于当前指南推荐。
- 当前扩展性携带者筛查面板中相当大比例(73%)的疾病不符合作者所提标准。
关键数值与推荐
- 作者提出的具体标准旨在最大化临床实用性并减少患者压力、后续检测的不必要费用及临床医生时间。
临床怎么用
- 作者鼓励实验室和临床医生合作,为希望获得生殖风险信息的患者创建最具临床实用性的筛查面板。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Expanded carrier screening for autosomal-recessive conditions effectively identifies more carrier couples than traditional guideline-based carrier screening. However, clinically available expanded carrier screening panels include numerous conditions, some of which have questionable clinical utility as a result of very low carrier frequency, low or unknown testing sensitivity, and mild or incompletely penetrant phenotypes. Using the 2013 American College of Medical Genetics and Genomics Position Statement on Prenatal and Preconception Expanded Carrier Screening and the 2017 American College of Obstetricians and Gynecologists' Committee Opinion on Carrier Screening in the Age of Genomic Medicine as guidance, we propose specific criteria for the development of expanded carrier screening panels that will maximize clinical utility and minimize patient stress, unnecessary cost of follow-up testing, and clinician time spent facilitating and performing follow-up counseling and testing. We identified 96 conditions that meet our proposed criteria, far more than current guidelines recommend. On the other hand, a considerable percentage (73%) of conditions on current expanded carrier screen panels does not meet our proposed criteria. The purpose of this commentary is to acknowledge the benefits of expanded panels, but to also recognize that in their current state, we are putting patients at risk for undue stress and spending excessive time and money on follow-up testing for remarkably rare or mild conditions and conditions with low screening performance. We encourage laboratories and clinicians to work together to create the most clinically useful screening panels for patients desiring reproductive risk information.
引用
- Stevens B, Krstic N, Jones M, et al. Finding Middle Ground in Constructing a Clinically Useful Expanded Carrier Screening Panel. Obstet Gynecol. 2017. PMID: 28697118. doi:10.1097/AOG.0000000000002139
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。